Fund Management At Engine No. 1 LLC Abb Vie Inc. Transaction History

Fund Management At Engine No. 1 LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $303,783 - $351,674	2,274 Added 9.9%	25,243 $3.76 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $201,415 - $250,648	1,520 Added 7.09%	22,969 $3.09 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $286,327 - $329,749	1,980 Added 10.17%	21,449 $3.42 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $341,349 - $409,367	2,468 Added 14.52%	19,469 $3.15 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $113,004 - $129,609	-842 Reduced 4.72%	17,001 $2.28 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $395,795 - $503,184	2,876 Added 19.22%	17,843 $2.73 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $1.98 Million - $2.45 Million	14,967 New	14,967 $2.43 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.